Skip to content

Brain Function in Adolescent Eating Disorders and Healthy Peers

Neurocircuitry of Temperament and Motivated Behavior in Adolescent Eating Disorders

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03347565
Enrollment
155
Registered
2017-11-20
Start date
2017-07-21
Completion date
2026-05-08
Last updated
2026-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eating Disorder

Keywords

adolescents, healthy controls

Brief summary

This study of adolescent eating disorders (ED) will examine the association of temperament-based classifications, brain activation during incentive processing, and ED symptoms at time of scan and 1 year later to better understand the neurobiology and symptoms of ED. We will recruit 150 females currently ill with an ED and 50 controls ages 14-17 to investigate how temperaments reflecting greater inhibition, impulsivity, or effortful control correspond to 1) clinical symptoms and 2) the brain's response to anticipation and outcome of salient stimuli, and 3) by collecting follow-up clinical data one year later, identify how temperament-based subtypes predict ED symptom change (e.g., clinical prediction). Data collection will rely on a technology called functional magnetic resonance imaging (fMRI).

Interventions

None listed

Sponsors

University of California, San Diego
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
14 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* Female * Meet DSM-V criteria for an Eating Disorder or Never met criteria for an Eating disorder * Medically stable * Post-Pubertal (must have started menses, but subsequent loss of menses secondary to ED is fine).

Exclusion criteria

* Psychotic illness/other mental illness requiring hospitalization * Current dependence on drugs or alcohol * Physical conditions known to influence eating or weight (e.g, diabetes mellitus, pregnancy). * On psychoactive medication * Organic brain syndromes, delirium, psychotic disorders, or intellectual disability * Neurological or medical disorders such as seizure disorder * Any contraindication to undergoing an MRI * Major depressive disorder * Left handed

Design outcomes

Primary

MeasureTime frameDescription
Brain function1 year (fMRI Scan)Functional Magnetic Resonance imaging will be used to assess brain activation associated with inhibition, impulsivity, and control

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 14, 2026